Literature DB >> 23110945

Federal legislation and the advancement of neonatal drug studies.

Jason R Wiles1, Alexander A Vinks, Henry Akinbi.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23110945      PMCID： PMC3723457          DOI： 10.1016/j.jpeds.2012.08.034

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  29 in total

1.  Unapproved and off-label use of drugs in a children's hospital.

Authors:  G W 't Jong; A G Vulto; M de Hoog; K J Schimmel; D Tibboel; J N van den Anker
Journal:  N Engl J Med       Date:  2000-10-12       Impact factor: 91.245

Review 2.  Unlicensed and off-label drug use in children: implications for safety.

Authors:  Imti Choonara; Sharon Conroy
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

3.  Reflections on errors in neonatology: II. The "Heroic" years, 1950 to 1970.

Authors:  Alex F Robertson
Journal:  J Perinatol       Date:  2003-03       Impact factor: 2.521

4.  Learning about the safety of drugs--a half-century of evolution.

Authors:  Jerry Avorn
Journal:  N Engl J Med       Date:  2011-12-08       Impact factor: 91.245

5.  Important role of population pharmacokinetic/pharmacodynamic modeling in pediatric therapeutics.

Authors:  Alexander A Vinks
Journal:  J Pediatr       Date:  2011-07-20       Impact factor: 4.406

6.  Antibiotics for the newborn infant; a discussion of dosages.

Authors:  S J Yaffe
Journal:  Clin Pediatr (Phila)       Date:  1965-11       Impact factor: 1.168

7.  Therapeutic orphans.

Authors:  H Shirkey
Journal:  J Pediatr       Date:  1968-01       Impact factor: 4.406

8.  Unlicensed and off-label medication use in a neonatal intensive care unit: a prospective study.

Authors:  Joseph Barr; Galit Brenner-Zada; Eli Heiman; Gideon Pareth; Mordechai Bulkowstein; Revital Greenberg; Matitiahu Berkovitch
Journal:  Am J Perinatol       Date:  2002-02       Impact factor: 1.862

9.  Relationship of prolonged pharmacologic serum levels of vitamin E to incidence of sepsis and necrotizing enterocolitis in infants with birth weight 1,500 grams or less.

Authors:  L Johnson; F W Bowen; S Abbasi; N Herrmann; M Weston; L Sacks; R Porat; G Stahl; G Peckham; M Delivoria-Papadopoulos
Journal:  Pediatrics       Date:  1985-04       Impact factor: 7.124

10.  Drug utilization and reported adverse reactions in hospitalized children.

Authors:  A A Mitchell; P Goldman; S Shapiro; D Slone
Journal:  Am J Epidemiol       Date:  1979-08       Impact factor: 4.897
View more
  8 in total

1.  The role and limitations of Cochrane reviews at the bedside: a systematic synopsis of five pediatric subspecialties.

Authors:  Sascha Meyer; Martin Poryo; Sara Khosrawikatoli; Yvonne Goda; Michael Zemlin
Journal:  Wien Med Wochenschr       Date:  2017-03-02

2.  Pharmacological options for BPD prevention: steps for better clinical trial design.

Authors:  R M Viscardi
Journal:  J Perinatol       Date:  2014-09       Impact factor: 2.521

Review 3.  Monitoring neonates for ototoxicity.

Authors:  Angela C Garinis; Alison Kemph; Anne Marie Tharpe; Joern-Hendrik Weitkamp; Cynthia McEvoy; Peter S Steyger
Journal:  Int J Audiol       Date:  2017-06-22       Impact factor: 2.117

4.  New Information on Old Medicinal Products: A Cross-Sectional Analysis of Guidance for Paediatric Use for Substances on the European Priority List of Off-Patent Medicinal Products.

Authors:  Ann-Katrine Birkelund Mogensen; Helle Christiansen; Marie Louise De Bruin; Christine Erikstrup Hallgreen
Journal:  Paediatr Drugs       Date:  2022-08-13       Impact factor: 3.930

5.  Pharmacokinetics of Oral Methadone in the Treatment of Neonatal Abstinence Syndrome: A Pilot Study.

Authors:  Jason R Wiles; Barbara Isemann; Tomoyuki Mizuno; Meredith E Tabangin; Laura P Ward; Henry Akinbi; Alexander A Vinks
Journal:  J Pediatr       Date:  2015-09-11       Impact factor: 4.406

6.  Current management of neonatal abstinence syndrome secondary to intrauterine opioid exposure.

Authors:  Jason R Wiles; Barbara Isemann; Laura P Ward; Alexander A Vinks; Henry Akinbi
Journal:  J Pediatr       Date:  2014-06-16       Impact factor: 4.406

Review 7.  Suggestions for Model-Informed Precision Dosing to Optimize Neonatal Drug Therapy.

Authors:  Joshua C Euteneuer; Suyog Kamatkar; Tsuyoshi Fukuda; Alexander A Vinks; Henry T Akinbi
Journal:  J Clin Pharmacol       Date:  2018-09-11       Impact factor: 3.126

8.  Use of off-label and unlicensed medicines in neonatal intensive care.

Authors:  Haline Tereza Matias de Lima Costa; Tatiana Xavier Costa; Rand Randall Martins; Antônio Gouveia Oliveira
Journal:  PLoS One       Date:  2018-09-25       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.